AI + live data · analyst records & stock signals

Leaderboard Membership Builder

Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @crypto_biotech

$VLTLF

BULLISH2026-06-28

Price around the call

↑ 2026-06-28

By horizonMaturing · ~1 trading days to go

1d

✗ -4.1%

5d

✗ -5.0%

21d

…

Original post

BioPharm_the_Magnificent · 2026-06-28

$VLTLF $LIB.v CEO Alex Wylie made the right call by keeping their DLE technology as a proprietary trade secret instead of filing US patents. Patents are a trap in today’s world. The moment you file, you hand over a complete public blueprint: Detailed descriptions, claims, operating parameters, and methods that anyone on the planet can read for free. Chinese competitors and other bad actors don’t even need to reverse-engineer your deployed units. They just download the patent and get straight to work copying or designing around it. Why give them that advantage? Trade secrets force them to figure it out the hard way (if they can at all), without you doing the work for them. In fields like DLE where processes involve specific chemistries and conditions, that disclosure is extre